Literature DB >> 29298894

Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice.

Xiujie Sun1, Kshama Gupta1, Bogang Wu1, Deyi Zhang1, Bin Yuan1, Xiaowen Zhang1, Huai-Chin Chiang1, Chi Zhang1, Tyler J Curiel1, Michelle P Bendeck2, Stephen Hursting3, Yanfen Hu4, Rong Li5.   

Abstract

Discoidin domain receptor 1 (DDR1) is a collagen receptor that mediates cell communication with the extracellular matrix (ECM). Aberrant expression and activity of DDR1 in tumor cells are known to promote tumor growth. Although elevated DDR1 levels in the stroma of breast tumors are associated with poor patient outcome, a causal role for tumor-extrinsic DDR1 in cancer promotion remains unclear. Here we report that murine mammary tumor cells transplanted to syngeneic recipient mice in which Ddr1 has been knocked out (KO) grow less robustly than in WT mice. We also found that the tumor-associated stroma in Ddr1-KO mice exhibits reduced collagen deposition compared with the WT controls, supporting a role for stromal DDR1 in ECM remodeling of the tumor microenvironment. Furthermore, the stromal-vascular fraction (SVF) of Ddr1 knockout adipose tissue, which contains committed adipose stem/progenitor cells and preadipocytes, was impaired in its ability to stimulate tumor cell migration and invasion. Cytokine array-based screening identified interleukin 6 (IL-6) as a cytokine secreted by the SVF in a DDR1-dependent manner. SVF-produced IL-6 is important for SVF-stimulated tumor cell invasion in vitro, and, using antibody-based neutralization, we show that tumor promotion by IL-6 in vivo requires DDR1. In conclusion, our work demonstrates a previously unrecognized function of DDR1 in promoting tumor growth.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  DDR1; IL-6; adipose stromal cells; breast cancer; cancer biology; cell invasion; cytokine; discoidin domain receptor 1; extracellular matrix; mammary tumor; stromal–vascular fraction; tumor cell biology; tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 29298894      PMCID: PMC5827455          DOI: 10.1074/jbc.RA117.000672

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer.

Authors:  Neil M Iyengar; Xi Kathy Zhou; Ayca Gucalp; Patrick G Morris; Louise R Howe; Dilip D Giri; Monica Morrow; Hanhan Wang; Michael Pollak; Lee W Jones; Clifford A Hudis; Andrew J Dannenberg
Journal:  Clin Cancer Res       Date:  2015-12-28       Impact factor: 12.531

2.  Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer.

Authors:  Louise R Howe; Kotha Subbaramaiah; Clifford A Hudis; Andrew J Dannenberg
Journal:  Clin Cancer Res       Date:  2013-08-19       Impact factor: 12.531

Review 3.  Significance of interleukin-6 (IL-6) in breast cancer (review).

Authors:  Heike Knüpfer; Rainer Preiss
Journal:  Breast Cancer Res Treat       Date:  2006-08-23       Impact factor: 4.872

Review 4.  The role of intratumoral and systemic IL-6 in breast cancer.

Authors:  Christine Dethlefsen; Grith Højfeldt; Pernille Hojman
Journal:  Breast Cancer Res Treat       Date:  2013-03-27       Impact factor: 4.872

5.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

6.  Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.

Authors:  Sarah M Dunlap; Lucia J Chiao; Leticia Nogueira; Jerry Usary; Charles M Perou; Lyuba Varticovski; Stephen D Hursting
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-15

7.  Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer.

Authors:  Mengmeng Niu; Solange Valdes; Youssef W Naguib; Stephen D Hursting; Zhengrong Cui
Journal:  Mol Pharm       Date:  2016-04-26       Impact factor: 4.939

8.  Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies.

Authors:  Inge Verbrugge; Jim Hagekyriakou; Leslie L Sharp; Mara Galli; Alison West; Nicole M McLaughlin; Hélène Duret; Hideo Yagita; Ricky W Johnstone; Mark J Smyth; Nicole M Haynes
Journal:  Cancer Res       Date:  2012-05-08       Impact factor: 12.701

Review 9.  Discoidin domain receptor functions in physiological and pathological conditions.

Authors:  Birgit Leitinger
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

Review 10.  Tumor-associated stromal cells as key contributors to the tumor microenvironment.

Authors:  Karen M Bussard; Lysette Mutkus; Kristina Stumpf; Candelaria Gomez-Manzano; Frank C Marini
Journal:  Breast Cancer Res       Date:  2016-08-11       Impact factor: 6.466

View more
  8 in total

1.  Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness.

Authors:  Marco Prunotto; Rafael Fridman; R Daniel Bonfil; Wei Chen; Semir Vranic; Anjum Sohail; Dongping Shi; Hyejeong Jang; Hyeong-Reh Kim
Journal:  Cancer Cell Int       Date:  2021-09-21       Impact factor: 6.429

2.  Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma.

Authors:  Kshama Gupta; Jeremy C Jones; Virginea De Araujo Farias; Yuri Mackeyev; Pankaj K Singh; Alfredo Quiñones-Hinojosa; Sunil Krishnan
Journal:  Front Oncol       Date:  2022-05-18       Impact factor: 5.738

3.  MRIP Regulates the Myosin IIA Activity and DDR1 Function to Enable Collagen Tractional Remodeling.

Authors:  Nuno M Coelho; Andrew Wang; Petar Petrovic; Yongqiang Wang; Wilson Lee; Christopher A McCulloch
Journal:  Cells       Date:  2020-07-11       Impact factor: 6.600

4.  Discoidin Domain Receptor 1 Expression in Colon Cancer: Roles and Prognosis Impact.

Authors:  Kaouther Ben Arfi; Christophe Schneider; Amar Bennasroune; Nicole Bouland; Aurore Wolak-Thierry; Guillaume Collin; Cuong Cao Le; Kevin Toussaint; Cathy Hachet; Véronique Lehrter; Stéphane Dedieu; Olivier Bouché; Hamid Morjani; Camille Boulagnon-Rombi; Aline Appert-Collin
Journal:  Cancers (Basel)       Date:  2022-02-13       Impact factor: 6.639

Review 5.  Genetic and pharmacological tools to study the role of discoidin domain receptors in kidney disease.

Authors:  Corina M Borza; Gema Bolas; Ambra Pozzi
Journal:  Front Pharmacol       Date:  2022-09-28       Impact factor: 5.988

6.  Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer.

Authors:  Bogang Wu; Xiujie Sun; Harshita B Gupta; Bin Yuan; Jingwei Li; Fei Ge; Huai-Chin Chiang; Xiaowen Zhang; Chi Zhang; Deyi Zhang; Jing Yang; Yanfen Hu; Tyler J Curiel; Rong Li
Journal:  Oncoimmunology       Date:  2018-08-23       Impact factor: 8.110

7.  Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts.

Authors:  Benjamin Wasinski; Anjum Sohail; R Daniel Bonfil; Seongho Kim; Allen Saliganan; Lisa Polin; Mohamad Bouhamdan; Hyeong-Reh C Kim; Marco Prunotto; Rafael Fridman
Journal:  Sci Rep       Date:  2020-02-11       Impact factor: 4.379

8.  Silencing of sinusoidal DDR1 reduces murine liver metastasis by colon carcinoma.

Authors:  Irene Romayor; Iker Badiola; Aitor Benedicto; Joana Márquez; Alba Herrero; Beatriz Arteta; Elvira Olaso
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.